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Ca2+ binding to synaptotagmin 1 triggers fast
exocytosis of synaptic vesicles that have been
primed for release by SNARE-complex as-
sembly. Besides synaptotagmin 1, fast Ca2+-
triggered exocytosis requires complexins.
Synaptotagmin 1 and complexins both bind to
assembled SNARE complexes, but it is unclear
how their functions are coupled. Here we pro-
pose that complexin binding activates SNARE
complexes into a metastable state and that
Ca2+ binding to synaptotagmin 1 triggers fast
exocytosis by displacing complexin from meta-
stable SNARE complexes. Specifically, we dem-
onstrate that, biochemically, synaptotagmin 1
competes with complexin for SNARE-complex
binding, thereby dislodging complexin from
SNARE complexes in a Ca2+-dependent man-
ner. Physiologically, increasing the local con-
centration of complexin selectively impairs
fast Ca2+-triggered exocytosis but retains other
forms of SNARE-dependent fusion. The hy-
pothesis that Ca2+-induced displacement of
complexins from SNARE complexes triggers
fast exocytosis accounts for the loss-of-
function and gain-of-function phenotypes of
complexins and provides a molecular explana-
tion for the high speed and synchronicity of
fast Ca2+-triggered neurotransmitter release.
INTRODUCTION
When an action potential invades a nerve terminal, inflow-
ing Ca2+ stimulates fast, submillisecond neurotransmit-
ter release by synaptic vesicle exocytosis (Katz, 1969;Cell 1Su¨dhof, 2004). Fast synaptic exocytosis is triggered by
Ca2+ binding to synaptotagmin 1 (Fernandez-Chacon
et al., 2001) and is mediated by assembly of SNARE com-
plexes from the SNARE proteins synaptobrevin/VAMP,
syntaxin 1, and SNAP-25 (reviewed in Brunger, 2005;
Sorensen, 2005). In addition to fast synchronous Ca2+-
triggered release, synapses exhibit slower asynchronous
Ca2+-triggered release that also depends on SNARE
proteins but is independent of synaptotagmin 1 (Geppert
et al., 1994; Deak et al., 2004).
Synaptotagmin 1 is a synaptic vesicle protein with two
C2 domains that both bind Ca
2+ (Fernandez-Chacon
et al., 2001; Fernandez et al., 2001). Biochemically, the
C2 domains of synaptotagmin 1 interact with negatively
charged phospholipids and synaptic SNARE proteins
(Perin et al., 1990; Bennett et al., 1992; Yoshida et al.,
1992; So¨llner et al., 1993; Davletov and Su¨dhof, 1993;
Li et al., 1995; Chapman et al., 1995; Banerjee et al.,
1996; Schiavo et al., 1997; Fernandez et al., 2001; Rick-
man et al., 2004; Bowen et al., 2005). The interaction of
synaptotagmin 1 with SNARE proteins has suggested a
direct action of synaptotagmin 1 on SNARE complexes
in triggering release. However, both Ca2+-dependent
and Ca2+-independent interactions of synaptotagmin 1
with SNARE complexes have been described, and it is
unclear which operate under physiological conditions
(see references cited above).
In addition to synaptotagmin 1, SNARE complexes bind
complexins (also called synaphins), small soluble proteins
that insert as an antiparallel a helix into a groove of the
four-helical bundle of the SNARE complex, but do not
bind to individual SNARE proteins or to synaptotagmin 1
(McMahon et al., 1995; Ishizuka et al., 1995; Pabst et al.,
2002; Bracher et al., 2002; Chen et al., 2002). In mice,
deletion of complexins selectively impairs fast Ca2+-trig-
gered release, but not fusion in general (Reim et al.,
2001). In particular, asynchronous slow Ca2+-triggered
release that is SNARE-complex dependent is not altered
by deletion of complexins. Hence, although complexins26, 1175–1187, September 22, 2006 ª2006 Elsevier Inc. 1175
and synaptotagmin 1 do not appear to interact with each
other, their deletions produce a similarly selective pheno-
type, suggesting that complexins and synaptotagmin 1
operate in the same pathway.
Not only deletion of complexins but also excess com-
plexin inhibits exocytosis (Ono et al., 1998; Itakura et al.,
1999; Archer et al., 2002; Giraudo et al., 2006; Schaub
et al., 2006). For example, a peptide from theSNARE-bind-
ing sequence of complexin inhibits neurotransmitter re-
lease in microinjected squid synapses (Tokumaru et al.,
2001). Although biophysical results rendered the specific
molecular mechanism proposed in this study (SNARE-
complex polymerization by complexin) unlikely (Bracher
et al., 2002; Chen et al., 2002; Hu et al., 2002; Pabst
et al., 2002), the overall conclusion mirrors that of other
studies introducing an excess of complexin into cells,
namely that complexins generally inhibit SNARE-depen-
dent fusion. This conclusion, however, does not agree
with the specific impairment of only fast Ca2+-triggered
release observed in complexin knockout (KO) mice (Reim
et al., 2001).
In the present study, we demonstrate that complexins
and synaptotagmin 1 act in the same pathway and com-
pete with each other for SNARE-complex binding and
that, similarly to the deletion of complexins, a local synap-
tic excess of complexin selectively blocks fast Ca2+-trig-
gered release, but not slow asynchronous release. These
results, together with the earlier structural studies of the
complexin-SNARE interaction (Chen et al., 2002), lead
us to propose that complexins promote full assembly of
SNARE complexes and simultaneously block completion
of the fusion reaction, thus leading to a metastable state
that is critical for synchronization of release during the
short time window when Ca2+ concentrations are high.
We hypothesize that primed metastable vesicles form
the substrate for synaptotagmin 1, which triggers fast
synchronous release upon Ca2+ influx by binding to
SNARE complexes, displacing complexin, and coupling
the SNARE complex to phospholipids. These studies sug-
gest a mechanism not only for how synaptotagmin 1 acts
in triggering release but also for how the metastable state
of primed vesicles is maintained by complexins in prepa-
ration for synaptotagmin 1 action.
RESULTS
Binding of Purified Synaptotagmin
1 to SNARE Proteins
To examine the Ca2+-dependent and Ca2+-independent
binding of synaptotagmin 1 to SNARE complexes, we
immobilized GST-synaptobrevin on glutathione beads, re-
constituted the SNARE complex on the beads in situ with
recombinant SNAREmotifs fromSNAP-25 and syntaxin 1,
and measured the Ca2+-dependent binding of the re-
combinant C2A/B domain fragment from synaptotagmin
1 (residues 140–421) in buffers containing 50–200 mM
NaCl (Figures 1B and 1C). As a negative control, we
used beads containing only GST-synaptobrevin (data1176 Cell 126, 1175–1187, September 22, 2006 ª2006 Elsevienot shown). We found that synaptotagmin 1 binding to
SNARE complexes was activated at low and abolished
at high ionic strengths. Binding was strictly Ca2+ depen-
dent at intermediate, physiological ionic strengths but be-
came at least partially Ca2+ independent at low ionic
strengths (Figures 1B and 1C). We detected no binding
of synaptotagmin 1 to GST-synaptobrevin alone (data
not shown). The same experiment performed in the re-
verse orientation with immobilized GST-synaptotagmin
yielded similar results, except that more Ca2+-indepen-
dent binding was observed (see Figure S1 in the Supple-
mental Data available with this article online). Titrations
revealed that, in these binding reactions, synaptotagmin
1 and SNARE complexes formed stoichiometric com-
plexes with a nanomolar affinity that was 7-fold lower
than that of the complexin-SNARE interaction (Figure S2).
Viewed together, these data show that synaptotagmin 1
binds to assembled SNARE complexes in a precarious
balance dictated by the ionic strength and the Ca2+ con-
centration and that, under nearly physiological conditions,
Ca2+-dependent binding is favored.
Synaptotagmin 1 and Complexin Compete
for SNARE-Complex Binding
Since synaptotagmin 1 and complexin both bind to
SNAREs, we askedwhether they compete with each other
for binding. We tested full-length wild-type complexin 1
(Cpx); full-length complexin 1 containing point mutations
in the central SNARE-binding sequence (CpxM; mutations
used for these and all experiments described below were
R48A/R59A/K69A/Y70A); and N-terminally truncated
complexin 1 that lacks the first 40 residues, which are
not involved in SNARE-complex binding (CpxD). Full-
length and truncated complexins bound tightly to SNARE
complexes, whereas the mutant complexin did not
(Figure S3). Titrations revealed that SNARE complexes
were quantitatively displaced from synaptotagmin 1 by
full-length complexin at submicromolar concentrations,
but not by mutant complexin (Figures 1D–1E). Interest-
ingly, N-terminally truncated complexin displaced only
50% of the SNARE complexes. The competition was
observed independently of whether Ca2+ was present or
absent, presumably because we carried out these exper-
iments under saturating conditions that render SNARE
binding to synaptotagmin 1 Ca2+ independent (Figure S1).
Characterization of the Ca2+-Dependent Binding of
Native Synaptotagmin 1 to Brain SNARE Complexes
To study the relation of complexin and synaptotagmin 1
binding to SNARE complexes with native proteins, we
immunoprecipitated brain proteins solubilized in Triton
X-100 (Figure 2). We immunoprecipitated SNARE com-
plexeswith syntaxin 1 or synaptobrevin 2 antibodies,mea-
sured the amounts of coimmunoprecipitated proteins by
quantitative immunoblotting with 125I-labeled secondary
antibodies at different ionic strengths in the presence
and absence of Ca2+, and normalized the protein amounts
for the immunoprecipitated protein to correct forr Inc.
Figure 1. Competitive Binding of Synaptotagmin 1 and Complexin to SNARE Complexes
(A) Schematic diagrams of syntaxin 1 (yellow), SNAP-25 (orange), synaptobrevin 2/VAMP (red), synaptotagmin 1 (blue), and complexins (green).
(B and C) Effect of ionic strength on the binding of the double C2 domain fragment from synaptotagmin 1 to immobilized SNARE complexes attached
to the beads by excess GST-synaptobrevin. Binding was carried out with and without 1 mM free Ca2+. Controls with GST-synaptobrevin alone
exhibited no binding (data not shown). Data shown are means ± SEMs (n = 3).
(D and E) Displacement of SNARE complexes from synaptotagmin 1 by increasing concentrations of wild-type and mutant complexins (Cpx =
full-length complexin 1; CpxD = N-terminally truncated complexin 1 lacking residues 1–40; CpxM = mutant full-length complexin 1 that does not
bind to SNARE complexes; see Figure S3). (D) shows representative gels, while (E) depicts quantitations based on Coomassie-stained SDS gels
(means ± SEMs; n = 3).differences in yield. We found that, similar to the binding of
recombinant proteins, binding of native synaptotagmin 1
to SNARE complexes was largely independent of Ca2+ at
low ionic strength, predominantly Ca2+ dependent at inter-
mediate (physiological) ionic strength, and inhibited at high
ionic strength (Figure 2A).
Complexin Displaces Synaptotagmin 1 from Native
Brain SNARE Complexes
To determine whether complexin and synaptotagmin 1
also compete with each other for binding to native SNARE
complexes in solution, we performed the SNARE immuno-
precipitations in thepresenceof increasing concentrations
of exogenous complexins (Figure 2B). Without additions,
the immunoprecipitates contained endogenous complex-Cell 1ins. After addition of excess exogenous complexins, how-
ever, only exogenous complexins were present in the
immunoprecipitated SNARE complex. (Note that the N-
terminally truncated complexin 1 still binds effectively to
SNARE complexes.) Rab3 and synaptophysin, analyzed
as control proteins, were not coimmunoprecipitated.
We quantitated the displacement of synaptotagmin 1
from native SNARE complexes by complexin and also
examined a-SNAP binding because a-SNAP is known
to compete with complexin for binding to SNAREs
(McMahon et al., 1995). Complexin binding was deter-
minedasacontrol to ensure that theexogenous complexin
was incorporated into the precipitated complex. Nanomo-
lar complexin concentrations displaced >80%of synapto-
tagmin1 from the immunoprecipitatedSNAREcomplexes.26, 1175–1187, September 22, 2006 ª2006 Elsevier Inc. 1177
Figure 2. Immunoprecipitation Analysis
of Synaptotagmin 1 and Complexin Bind-
ing to Native SNARE Complexes
(A) Effect of ionic strength and Ca2+ on synap-
totagmin 1 binding to native brain SNARE com-
plexes. SNARE complexes were immunopre-
cipitated at the indicated NaCl concentrations
with antibodies to syntaxin 1 or synaptobrevin
2 with or without 1 mM free Ca2+. Immuno-
precipitated proteins were quantified by immu-
noblotting using 125I-labeled secondary anti-
bodies and phosphorimager detection and
were normalized for the amount of immunopre-
cipitated syntaxin 1 (n = 4) and synaptobrevin 2
(n = 3). Data shown are means ± SDs.
(B) Representative immunoprecipitations from
brain homogenates with polyclonal syntaxin 1
antibodies (left panel) and polyclonal and
monoclonal synaptobrevin 2 antibodies (cen-
tral and right panels) either without addition
or after addition of full-length (Cpx2–134) or N-
terminally truncated complexin 1 (Cpx41–134;
both 13.2 mM). Immunoprecipitates were im-
munoblotted with antibodies to synaptotagmin
1 (Syt 1), syntaxin 1 (Synt), SNAP-25, synapto-
brevin 2 (Syb 2), Rab3A, synaptophysin (Syp),
and complexin (Cpx; asterisk = position of the
truncated complexin that is coimmunoprecipi-
tated).
(C) Amounts of complexins, a-SNAP, and syn-
aptotagmin 1 coimmunoprecipitated with
SNARE complexes with antibodies to syntaxin
1 (left) or to synaptobrevin 2 (right) in 1mMCa2+
in the presence of increasing concentrations of
exogenous complexin 1. The relative amounts
of complexins, a-SNAP, and synaptotagmin 1
in the immunoprecipitates were measured by
quantitative immunoblotting (means ± SDs;
n = 4 independent experiments). Control ex-
periments showed that addition of up to 5 mM
recombinant complexin 1 did not significantly
change the amount of syntaxin 1 or SNAP-25
in the immunoprecipitates (data not shown).In contrast, complexin was less effective in displacing a-
SNAP from SNARE complexes (Figure 2C), consistent
with the idea that a-SNAP has a higher affinity for SNARE
complexes than complexin and synaptotagmin 1. In these1178 Cell 126, 1175–1187, September 22, 2006 ª2006 Elsevierexperiments, the complexin concentrations required for
displacement of synaptotagmin 1 fromSNARE complexes
were lower than in the recombinant protein experiments
(Figure 1E), possibly because the synaptotagmin 1Inc.
Figure 3. Synaptotagmin 1 Displaces Complexin from Membrane-Attached SNARE Complexes in a Ca2+-Dependent Manner
(A) Confocal micrographs of supported bilayers containing reconstituted SNARE complexes loaded with 50 nM fluorescent complexin (residues
26–83; labeled with BODIPY-FL). Bilayers were deposited in microfluidic channels (0.2 mm width) and washed with buffer containing 100 mM KCl
and the indicated additions (Syt = 1 mM synaptotagmin 1 cytoplasmic region).
(B) An analogous experiment in which SNARE complexes in the bilayer were loaded with fluorescent complexin and then washed with Ca2+-
containing buffer and increasing concentrations of synaptotagmin 1 as indicated. Eachwashwith synaptotagmin 1was followed by awashwith buffer
alone.
(C) Displacement of prebound fluorescent complexin from SNARE complexes by synaptotagmin 1. Experiments were performed as in (B); average
fluorescence intensities measured under each condition were normalized to the control, in which fluorescently labeled complexin was added to a
supported bilayer lacking SNARE complexes (blue diamond). Without Ca2+, even the maximal synaptotagmin 1 concentration cannot displace
fluorescent complexin from the SNARE complexes (green circle). Data were fitted to a dose-response curve (EC50 = 23 ± 5 nM synaptotagmin 1;
Hill coefficient = 0.96 ± 0.02 [n = 3 independent experiments]). Data shown in (C)–(F) are means ± SDs.
(D) Ca2+ titration of the displacement of fluorescent complexin from SNARE complexes by 1 mM synaptotagmin 1. Experiments were performed as in
(C) with increasing concentrations of free Ca2+ (EC50 = 53 ± 14 mM Ca
2+; Hill coefficient = 1.24 ± 0.37).
(E) Displacement of prebound synaptotagmin 1 from SNARE complexes by fluorescent complexin. The displacement of synaptotagmin 1 bound to
the reconstituted SNARE complexes wasmeasured in 1mMCa2+ as the binding of increasing concentrations of fluorescent complexin (EC50 = 1.00 ±
0.65 mM; Hill coefficient = 0.53 ± 0.18). As a control, the red circle indicates the amount of 50 nM fluorescent complexin bound in the absence of
prebound synaptotagmin 1.
(F) Effect of ionic strength on the displacement of bound complexin from SNARE complexes by synaptotagmin 1. SNARE complexes were loaded
with fluorescent complexin, and the amount of complexin remaining after washing with 1 mM synaptotagmin 1 at different KCl concentrations was
quantified. Experiments were performed in the presence of 1 mM Ca2+ (red circles) or 1 mM EDTA (green circles).concentration is lower in brain homogenates or because
complexin binding to SNARE complexes is facilitated
when SNARE proteins contain transmembrane regions
(Hu et al., 2002; however, see Bowen et al., 2005).
Ca2+-Dependent Displacement of Complexin
by Synaptotagmin 1 in a Membrane-Attached
Environment
SNARE proteins and synaptotagmin 1 are normally em-
bedded in membranes, whereas all experiments up until
now were performed in a nonmembranous environment.Cell 1To examine the role of Ca2+ in the binding of synaptotag-
min 1 to SNARE complexes in a physiological membra-
nous environment, and to test whether synaptotagmin 1
can displace complexin from SNARE complexes (and not
only whether complexin can displace synaptotagmin 1),
we reconstituted membrane-bound SNARE complexes
into a supported bilayer deposited within a microfluidic
channel. We then bound fluorescently labeled complexin
to the complexes andmeasured the ability of recombinant
synaptotagmin 1 to displace complexin from the SNARE
complexes as a function of Ca2+ (Figure 3A).26, 1175–1187, September 22, 2006 ª2006 Elsevier Inc. 1179
Synaptotagmin 1 quantitatively displaced complexin
from SNARE complexes in the presence, but not the ab-
sence, of Ca2+. In displacing complexin, synaptotagmin
1 exhibited an EC50 of 23 ± 5 nM (Figures 3A–3C) and a
micromolar apparent Ca2+ affinity (EC50 = 53 ± 14 mM;
Figure 3D). All of these experiments were performed in
a nearly physiological salt solution (100 mM KCl and
25 mMHEPES-NaOH), suggesting that, in a membranous
environment, synaptotagmin 1 powerfully dislodges com-
plexin from SNARE complexes. To probe whether com-
plexin in a membranous environment can in turn displace
synaptotagmin 1, we measured the binding of fluores-
cently labeled complexin to membrane-attached SNARE
complexes containing prebound synaptotagmin 1 (Fig-
ure 3E). Without prebound synaptotagmin 1, 50 nM com-
plexin quantitatively bound to the SNARE complexes.
With prebound synaptotagmin 1, by contrast, micromolar
complexin concentrations were required for binding, with
an apparent affinity 40-fold lower than that of the
displacement of complexin by synaptotagmin 1 (EC50 =
1.0 ± 0.2 mM). Similar to the GST pull-downs and immuno-
precipitation experiments, high ionic strength inhibited the
displacement of complexin from SNARE complexes by 1
mM synaptotagmin 1 (Figure 3F). As opposed to these ex-
periments, however, low ionic strength (0 and 50 mM KCl)
did not enable synaptotagmin 1 to displace complexin
from SNARE complexes in a Ca2+-independent manner.
This suggests that, in a membranous environment, lower-
ing the ionic strength does not activate Ca2+-independent
binding of synaptotagmin 1 to SNARE complexes. Overall,
these data show that, under close to physiological condi-
tions in a membranous environment, synaptotagmin 1
binds to SNARE complexes in a strictly Ca2+-dependent
manner and effectively displaces complexin from SNARE
complexes.
Synaptically Targeted Complexin/Synaptobrevin
Fusion Protein Inhibits Spontaneous
Synaptic Activity
A possible interpretation of the biochemical data is that
complexins serve as fusion clamps that are ‘‘unclamped’’
when Ca2+ binding to synaptotagmin 1 triggers the dis-
placement of complexin from SNARE complexes. A simi-
lar hypothesis was advanced in experiments in which
transfected cells that displayed surface-exposed SNARE
proteins or liposomes with reconstituted SNARE proteins
were fused in vitro; in both cases, addition of excess com-
plexin inhibited fusion, consistent with a clamp function for
complexin (Giraudo et al., 2006; Schaub et al., 2006).
However, the clamp hypothesis is at odds with the com-
plexin KO phenotype, which demonstrates that complex-
ins are activators, not inhibitors, of fusion (Reim et al.,
2001). It is possible that the KO analyses are misleading
because of compensatory effects or that the in vitro fusion
experiments are misleading because the assays using
surface-exposed SNAREs in transfected cells or lipo-
somes do not measure a normal synaptic membrane-fu-
sion reaction. Thus, to directly test the effect of excess1180 Cell 126, 1175–1187, September 22, 2006 ª2006 Elseviercomplexin on SNARE-mediated synaptic membrane fu-
sion, we constructed a complexin/synaptobrevin fusion
protein that increases the local concentration of com-
plexin at the synapse. This fusion protein is composed
of an N-terminal complexin, a central synaptobrevin, and
a C-terminal Venus-YFP (Figure 4A). Complexin is sepa-
rated from synaptobrevin by a flexible linker to allow fold-
ing back of complexin onto the SNARE complex into
which the synaptobrevin has been incorporated, thereby
increasing the local concentration of complexin at the
site of synaptic SNARE-complex formation. Experiments
with recombinant proteins confirmed that the complexin/
synaptobrevin fusion protein blocks synaptotagmin 1
binding to SNARE complexes but has no effect on
a-SNAP binding (Figure S4). In contrast, a fusion protein
with mutant complexin that does not bind to SNARE com-
plexes fully allowed synaptotagmin 1 binding.
We expressed the complexin/synaptobrevin proteins in
dissociated cortical neurons at day 5 in vitro using lentivi-
ral delivery. Immunoblots revealed that these proteins
were expressed at levels similar to those of endogenous
synaptobrevin (Figure 4B). Imaging documented that the
complexin/synaptobrevin proteins were highly concen-
trated in presynaptic terminals, where they colocalized
with FM5-95, an activity-dependent marker of synaptic
vesicles (Figure 4C and Figure S5). We analyzed the effect
of the complexin/synaptobrevin fusion protein on synaptic
transmission using whole-cell voltage-clamp recordings
on day 14–16 in culture, when neurons display robust
postsynaptic responses to extracellular stimulation (Max-
imov and Su¨dhof, 2005). Recordings of spontaneous re-
lease events revealed that thewild-type but not themutant
fusion protein reduced the rate of spontaneous mini
events 3-fold (Figures 4D and 4E) but had no effect on
the size of spontaneousmini events (Figure 4F), consistent
with a presynaptic role in release.
The Complexin/Synaptobrevin Fusion
Protein Inhibits Fast Ca2+-Triggered
Neurotransmitter Release
To determine which modes of release are perturbed by
the local increase in the concentration of complexin in
synapses, we measured inhibitory postsynaptic currents
(IPSCs) in the presence of glutamate-receptor blockers
(50 mM APV and 20 mM CNQX). We compared IPSCs ob-
tained in noninfected wild-type neurons, in neurons from
synaptotagmin 1 and synaptobrevin 2 KO mice, and in
wild-type neurons expressing complexin/synaptobrevin
proteins. Initially, we analyzed responses to single action
potentials (Figure 5A). Expression of the full-length or
N-terminally truncated complexin/synaptobrevin fusion
proteins led to an 80% depression of the amplitude and
the charge transfer of the IPSCs (Figure 5B and 5C). The
control complexin/synaptobrevin fusion proteinwith amu-
tation that inactivates SNARE-complex binding by com-
plexin had no significant effect on the size of the IPSCs,
demonstrating that the SNARE-binding activity of com-
plexin is responsible for the inhibitory effect. The inhibitoryInc.
Figure 4. Expression and Localization of
Complexin/Synaptobrevin Fusion Pro-
tein in Cultured Cortical Neurons: Effect
on Spontaneous Release Events
(A) Schematic diagram of the structure of com-
plexin (Cpx) and complexin/synaptobrevin 2
fusion proteins. Expressed proteins contain
full-length complexin 1 (Cpx and Cpx-Syb),
N-terminally truncated wild-type complexin 1
(CpxD-Syb; residues 41–134), and N-terminally
truncated mutant complexin 1 that lacks
SNARE binding (CpxDM-Syb with the R48A/
R59A/K69A/Y70A mutation; Figure S3). Com-
plexin is fused to full-length synaptobrevin
with a 49 residue linker, and fluorescent Venus
protein is fused C-terminally to complexin or
Cpx-Syb.
(B) Immunoblot analysis of various synaptic
proteins (as indicated on the right) and Cpx-
Syb fusion proteins in cortical neurons infected
with Cpx-Syb lentiviruses.
(C) Localization of the CpxD-Syb fusion protein
(visualized via its Venus fluorescence, green) in
neurons whose synapses were loaded with
FM5-95 (red). Fluorescent images were over-
laid with bright-field DIC to visualize neuronal
cell bodies and processes. Insets illustrate co-
localization of CpxD-Syb with FM5-95-positive
synaptic puncta in the regionmarked by awhite
box on the left (see also Figure S5).
(D) Representative traces of miniature inhibi-
tory postsynaptic currents (mIPSCs) monitored
in 1 mM tetrodotoxin, 20 mM CNQX, and 50 mM
AP5 from noninfected wild-type neurons or
wild-type neurons expressing CpxD-Syb or
CpxDM-Syb fusion proteins. Scale bars apply
to all traces.
(E and F) Average frequency (E) and amplitude
(F) of mIPSCs monitored in noninfected
neurons or neurons expressing CpxD-Syb or
CpxDM-Syb (means ± SEMs; numbers of neu-
rons analyzed [n] in three independent cultures
are indicated in the bars).effect of the wild-type complexin/synaptobrevin protein
was indistinguishable from that of the synaptotagmin 1
deletion, but less than that of the synaptobrevin 2 deletion,
presumably because the asynchronous release remains in
the synaptotagmin 1 KO but is depressed together with
the synchronous release in synaptobrevin 2 KO mice
(Geppert et al., 1994; Deak et al., 2004).Cell 1Constitutive Complexin Binding to SNARE
Complexes Does Not Block Asynchronous Release
Does transient expression of the complexin/synaptobre-
vin fusion protein fully impair exocytosis, similar to the
deletion of synaptobrevin 2 as suggested by the global
overexpression studies, or does it specifically block exo-
cytosis triggered by Ca2+ binding to synaptotagmin 1 as26, 1175–1187, September 22, 2006 ª2006 Elsevier Inc. 1181
suggested from the analysis of the complexin knockout?
To distinguish between these two possibilities, we exam-
ined the effects of the complexin/synaptobrevin fusion
proteins on release triggered by trains of action potentials
(100 APs at 10 Hz). In synaptobrevin 2 KO neurons, synap-
tic responses remain suppressed during high-frequency
stimulus trains (Deak et al., 2004), with a total amount of
release that was <5% of the release of wild-type controls
over the entire stimulus train (Figure 6A). In synaptotagmin
1-deficient neurons, in contrast, synaptic responses are
only initially abnormal during a high-frequency stimulus
Figure 5. Expression of a Complexin/Synaptobrevin Fusion
Protein in Wild-Type Neurons Impairs Synaptic Responses
Triggered by Single Action Potentials
(A) Representative IPSCs recorded from noninfected wild-type neu-
rons; synaptotagmin 1- and synaptobrevin 2-deficient neurons; and
wild-type neurons infected with lentiviruses encoding soluble com-
plexin, CpxD-Syb, or CpxDM-Syb. IPSCs were triggered by isolated
APs at 0.1 Hz (induced by local extracellular stimulation of adjacent
neurons) and were recorded in whole-cell voltage-clamp mode in
CNQX (20 mM) and AP5 (50 mM). Scale bars apply to all traces.
(B and C) Average amplitudes (B) and total charge transfers integrated
over 1.5 s (C) of IPSCs recorded from wild-type neurons, synaptotag-
min 1- and synaptobrevin 2-deficient neurons, and wild-type neurons
expressing the indicated complexin/synaptobrevin fusion proteins.
Numbers of neurons analyzed in each group are indicated in the
bars, data are from at least two independent cultures, and values are
normalized for the control analyzed in the same experiment. Data
shown are means ± SEMs.1182 Cell 126, 1175–1187, September 22, 2006 ª2006 Elseviertrain but quickly reach wild-type levels, and the total
amount of release over the entire train is not significantly
different from wild-type neurons (Maximov and Su¨dhof,
2005).
Analysis of the release produced during high-frequency
trains in neurons expressing complexin/synaptobrevin
proteins revealed a pattern indistinguishable from that ob-
served in synaptotagmin 1 KO neurons: The initial fast
synchronous responses were absent, but subsequent
asynchronous release that becomes dominant after three
to five action potentials was normal (Figure 6B). Quantita-
tion of the total synaptic charge transfer during the stimu-
lus train confirmed that in contrast to the synaptobrevin 2
KO neurons, neurons lacking synaptotagmin 1 or express-
ing the complexin/synaptobrevin fusion protein exhibited
nearly normal asynchronous release (Figure 6C). This re-
lease is indeed asynchronous because it is blocked by
EGTA-AM (Figure 6B), as previously demonstrated for
asynchronous release in wild-type neurons (Lu and Trus-
sell, 2000) and synaptotagmin 1 KO neurons (Maximov
and Su¨dhof, 2005). Moreover, plots of the time course of
cumulative charge transfer during the stimulus train dem-
onstrate that the initial four to five action potentials in-
duced little synaptic charge transfer in either synaptotag-
min 1 KO neurons or wild-type neurons expressing the
wild-type complexin/synaptobrevin protein. Later action
potentials, however, induce normal synaptic charge trans-
fers in these neurons (Figure 6D). Finally, initial responses
were desynchronized in synaptotagmin 1 KO neurons and
wild-type neurons expressing the wild-type complexin/
synaptobrevin protein, but not in wild-type neurons ex-
pressing the mutant complexin/synaptobrevin protein
(Figure 6E). This is evident from the fact that the first ten
responses during the stimulus train were highly synchro-
nized in wild-type control neurons and neurons express-
ing mutant complexin/synaptobrevin fusion protein, as
shown by the uniformly short rise times (although the
mutant complexin/synaptobrevin fusion protein did have
a moderate effect on rise times). In contrast, neurons ex-
pressing wild-type complexin/synaptobrevin fusion pro-
tein exhibited massive desynchronization as reflected in
a scattering of the rise times (Figure 6E).
DISCUSSION
Neurotransmitter release is an exquisitely regulated pro-
cess that exhibits a fast synchronous and a slower asyn-
chronous Ca2+-triggered component (Goda and Stevens,
1994; Su¨dhof, 2004). The basic machinery for fast syn-
chronous release is composed of SNARE proteins, which
mediate fusion; synaptotagmins, which serve as Ca2+
sensors; and complexins, which bind to SNARE com-
plexes (Geppert et al., 1994; Fernandez-Chacon et al.,
2001; Reim et al., 2001). Whereas SNAREs are also re-
quired for slow asynchronous release, synaptotagmins
and complexins are not. These data suggest that, after
synaptic vesicles are primed for release by SNARE-
complex assembly, two alternative pathways of releaseInc.
Figure 6. Expression of a Complexin/
Synaptobrevin Fusion Protein Causes
Loss of Fast Ca2+-Triggered Release
but Not of Asynchronous Ca2+-Triggered
Release
(A) Representative IPSCs during a 10 Hz stimu-
lus train for 10 s from wild-type neurons (Con-
trol), synaptotagmin 1-deficient neurons (Syt
1 KO), or synaptobrevin 2-deficient neurons
(Syb 2 KO).
(B) IPSCs monitored in the same conditions
from nontreated wild-type neurons expressing
CpxD-Syb andCpxDM-Syb or neurons express-
ing CpxD-Syb and treated for 5 min with
0.1 mM EGTA-AM. In (A) and (B), expanded
lower traces illustrate the initial onsets of
high-frequency responses (filtered at 50 Hz to
remove the stimulus artifacts). Scale bars apply
to all traces.
(C) Total synaptic charge transfer during
a 10 Hz stimulus train for 10 smonitored in non-
infected wild-type neurons, synaptotagmin 1
KO and synaptobrevin 2 KO neurons, or neu-
rons infected with Cpx-Syb lentiviruses (ana-
lyzed neuron numbers are indicated in the
bars; *p < 0.01; **p < 0.001). Data shown are
means ± SEMs.
(D) Average plots of the normalized cumulative
charge transferred during the first 1 s of 10 Hz
stimulation shown in (A) and (B).
(E) Top: aligned segments of the initial 10
IPSCs during a 10 Hz stimulus train to illustrate
that the synchronous responses become irreg-
ular in neurons expressing CpxD-Syb. Bottom:
plots of the 20%–80% rise times of individual
IPSCs triggered during a 10 Hz stimulus train
in control wild-type neurons and in neurons ex-
pressing CpxD-Syb or CpxDM-Syb. For each
group, data are from three different neurons.operate: a fast synchronous-release pathway that re-
quires synaptotagmins and complexins and dominates
whenever there is no accumulation of residual Ca2+ (e.g.,
during low-frequency stimulation or in the presence of
high Ca2+ buffer concentrations), and an asynchronous-
release pathway that dominates during repetitive stimula-
tion in the presence of increased bulk Ca2+. Although
previous observations defined complexins as essential
coactivators for synaptotagmin 1 in Ca2+-triggered fast
synchronous release, no biochemical connection be-
tween complexins and synaptotagmin 1 was known.
Several studies, including recent membrane-fusion
experiments using cells that display surface-exposedCell 1SNARE proteins (Giraudo et al., 2006) or liposomes that
contain reconstituted SNARE proteins (Schaub et al.,
2006), have proposed that complexins serve as fusion
clamps and that Ca2+ binding to synaptotagmin 1 relieves
this clamp by an unknown biochemical mechanism. This
proposal, however, is inconsistent with the phenotype of
the complexin KO mice, which suggests that complexins
are activators of fast synchronous release and do not
function as general clamps for SNARE-dependent fusion
(Reim et al., 2001). Moreover, the proposal that complex-
ins are general clamps for SNARE-dependent fusion is
incompatible with the present biochemical and physio-
logical data. Our biochemical results reveal a selective26, 1175–1187, September 22, 2006 ª2006 Elsevier Inc. 1183
Figure 7. Model for Complexin and Synaptotagmin 1 Function in Ca2+-Triggered Release
Docked vesicles containing unassembled SNARE complexes (top) are primed for release by partial SNARE-complex assembly catalyzed byMunc18,
Munc13, and RIM (step 1). The resulting primed vesicles form the substrate for two release pathways: asynchronous release, in which full assembly of
the SNARE complexes leads to fusion-pore opening followed by complete fusion (steps 2 and 3), and synchronous release, in which ‘‘superpriming’’
by binding of complexins to assembled SNARE complexes (step 4) activates and freezes SNARE complexes in a metastable state (referred to as
priming stage 2). This stage is then substrate for fast Ca2+ triggering of release when Ca2+ binding to synaptotagmin 1 induces its binding to phos-
pholipids and to SNARE complexes, with the latter reaction displacing complexin and resulting in fusion-pore opening (step 5). Again, opened fusion
pores can then dilate to complete fusion (step 6), although both steps 2 and 5 are potentially reversible—i.e., lack of dilation of the fusion pore could
lead to ‘‘kiss-and-run’’ exocytosis in these pathways. Note that steps 1 and 4 are also probably reversible, with a much faster forward than backward
speed. It is likely that step 1 is Ca2+ dependent, but it is unclear whether or not step 2 is Ca2+ dependent since it is possible that asynchronous release
is Ca2+ dependent solely because Ca2+ accelerates step 1, and step 2 has a finite probability. Thus, Ca2+ triggering of asynchronous release could
operate at the priming and/or the actual fusion step.competition of complexins with synaptotagmin 1 for
SNARE-complex binding, consistent with a functional
coupling between complexins and synaptotagmin 1
(which in turn is linked only to synchronous release, not
to general SNARE-dependent fusion). Our physiological
results demonstrate that a local excess of complexin in-
hibits fast synchronous release, presumably by outcom-
peting synaptotagmin 1, but has little effect on SNARE-
dependent asynchronous release.
We suggest an alternative interpretation of these data
(see model in Figure 7). Taking into consideration that ear-
lier structural studies have suggested that complexins sta-1184 Cell 126, 1175–1187, September 22, 2006 ª2006 Elsevierbilize the fully assembled SNARE complex (Chen et al.,
2002), we propose that complexins, by binding to SNARE
complexes that have been partially assembled during
priming, force completion of SNARE-complex assembly
and thereby transform vesicles into a ‘‘superprimed’’
metastable state. According to this hypothesis, complex-
ins activate vesicles by converting SNARE complexes
from a loose to a tightly assembled state that serves as
essential substrate for subsequent synaptotagmin 1 func-
tion. Complexin-activated vesicles are then triggered to
undergo fusion when Ca2+ binding to synaptotagmin 1
stimulates simultaneous binding of synaptotagmin 1 toInc.
SNARE complexes and phospholipids, thereby displacing
complexin. This hypothesis suggests that complexin is re-
quired for synaptotagmin 1 function, as revealed in the
complexin KOmice, because the metastable vesicle state
that is the substrate for synaptotagmin 1 action is depen-
dent on complexin. The evidence for this hypothesis is as
follows:
1. We show that synaptotagmin 1 binding to SNARE
complexes is controlled by a precarious balance
of ionic strength and Ca2+, providing an explanation
for the contradictions between previous studies
about the Ca2+ dependence of synaptotagmin 1
binding to SNARE complexes. At physiological ionic
strength, synaptotagmin 1 binds to SNARE com-
plexes in a Ca2+-regulated manner, although we
cannot rule out that the high local concentrations
of synaptotagmin 1 at the synapse render at least
some binding Ca2+ independent (see Figure 1, Fig-
ure 2, Figure 3, and Figures S1 and S2). At low ionic
strength, synaptotagmin 1 binding to SNARE com-
plexes is largely independent of Ca2+ in solution
(Figure 1 and Figure 2) but remains Ca2+ dependent
in a membranous environment (Figure 3). At high
ionic strength, no syntaptotagmin-1 binding to
SNARE complexes is observed under any condi-
tion. The strong Ca2+ dependence of synaptotag-
min 1 binding to SNARE complexes implies that
complexin binding to SNARE complexes dominates
prior to the action-potential-driven local increase
in Ca2+ at the terminal that leads to release (see
below).
2. Complexin and synaptotagmin 1 compete for bind-
ing to SNARE complexes. In the context of mem-
brane-bound SNARE complexes, synaptotagmin 1
is 40-fold more potent in displacing complexin
from SNARE complexes than complexin is in dis-
placing synaptotagmin 1 (Figure 3). The binding
competition between complexin and synaptotag-
min 1 shown here contradicts our previous finding
that complexin and synaptotagmin 1 can be coim-
munoprecipitated with each other (McMahon
et al., 1995). However, the previous coimmunopre-
cipitations were analyzed by sensitive but nonquan-
titative immunoblotting methods, which would
make trace amounts of bound protein (which could,
for example, be present because of SNARE-com-
plex oligomerization) appear to represent significant
binding. In contrast, for the present studies, we em-
ployed assays that measure stoichiometric binding,
making the results more accurate.
3. At physiological ionic strength, displacement of
complexin from SNARE complexes by synaptotag-
min 1 is absolutely dependent on Ca2+, presumably
because synaptotagmin 1 binding to SNARE com-
plexes under these conditions requires Ca2+ (Fig-
ure 3). Moreover, the apparent Ca2+ affinity of the
Ca2+-dependent displacement of complexin fromCell 1SNARE complexes is in the physiological range of
neurotransmitter release (50 mM; Figure 3).
4. Increasing the local concentration of complexin by
fusing it to synaptobrevin selectively suppresses
fast neurotransmitter release, creating a phenocopy
of the synaptotagmin 1 KO (Figure 5 and Figure 6).
This result is predicted by our model (Figure 7),
which suggests that complexin acts as an activator
of SNARE complexes that shares an overlapping
SNARE-complex binding site with synaptotagmin
1. Indeed, increases in the local synaptic complexin
concentration selectively suppress synaptotagmin
1 function, but—consistent with the model (Fig-
ure 7)—have little effect on SNARE-dependent
asynchronous release (Figure 5 and Figure 6). This
selective phenotype depends on the ability of com-
plexin to bind to SNARE complexes.
5. Considerable independent evidence in the literature
supports the presence of superprimed vesicles. For
example, different populations of primed vesicles
were defined physiologically in the calyx of Held
synapse (Trommershauser et al., 2003) and in
hippocampal synapses (Schlu¨ter et al., 2004) and
were hypothesized to involve different states of
SNARE-complex assembly in chromaffin cells (Xu
et al., 1999).
The crystal structure of the complex between com-
plexin and SNARE complexes (Chen et al., 2002) suggests
a mechanism by which complexins may activate vesicles
into a superprimed metastable state. Complexins bind to
and stabilize the C-terminal, membrane-proximal half of
SNARE complexes, indicating that, by forcing completion
of SNARE-complex assembly, complexins may induce
a strain on the participating membranes in which the re-
spective SNARE proteins reside (i.e., in the case of the
synapse, synaptobrevin on synaptic vesicles and syntaxin
on the plasma membrane). According to this hypothesis,
Ca2+ binding to synaptotagmin 1 then triggers vesicle fu-
sion by inducing the simultaneous binding of synaptotag-
min 1 to SNARE complexes and to phospholipids, thereby
displacing complexins and pulling the fusion pore open
(see model in Figure 7). This hypothesis suggests that
primed vesicles containing partly assembled SNARE
complexes either are substrates for asynchronous Ca2+-
triggered release or are activated by complexin binding
to SNARE complexes, which transforms them into a
substrate for Ca2+-triggered synchronous release. This
hypothesis still includes a clamp function for complexins
that, however, is secondary to their role in activating
SNARE complexes and does not involve clamping of
SNARE complexes as such, but only clamping of acti-
vated SNARE complexes produced by complexin binding
in the first place.
The interplay between SNARE complexes, complexins,
and synaptotagmin 1 is probably an evolutionarily old uni-
versal mechanism, as all organismswith a nervous system
appear to express both synapotagmin-1 and complexin26, 1175–1187, September 22, 2006 ª2006 Elsevier Inc. 1185
(see for example Dykes and Davies, 2004). Moreover, this
mechanism may be modulated by changing the affinity of
either complexin or synaptotagmin 1 for SNARE com-
plexes, as suggested by their phosphorylation (Hill et al.,
2006), a modulation that could cause dramatic changes
in the efficacy of synaptic transmission and remains to
be evaluated.
EXPERIMENTAL PROCEDURES
Binding Assays
Recombinant proteins were purified as GST-fusion proteins with or
without removal of GST (Sutton et al., 1998; Chen et al., 2002, 2006;
Fernandez et al., 2001). Quantitative GST-affinity chromatography
was performed with defined amounts of immobilized and soluble
proteins, quantified after SDS-PAGE using Coomassie staining or
quantitative immunoblotting, and analyzed with Prism software. For
a detailed description of these and other methods, see the Supple-
mental Data.
Immunoprecipitations
Immunoprecipitations were performed with Triton X-100-solubilized
rat brain proteins (McMahon et al., 1995) using polyclonal syntaxin 1
antibodies (U6250 or U6251) and polyclonal (P939) or monoclonal syn-
aptobrevin 2 antibodies (Cl69.1). Immunoprecipitated proteins were
quantified by immunoblotting using 125I-labeled secondary antibodies
and phosphorimager detection, and levels were normalized for the
amount of immunoprecipitated syntaxin 1 or synaptobrevin 2. In com-
petition experiments, controls showed that addition of 5 mM recombi-
nant complexin did not significantly change the syntaxin or SNAP-25
amount in the immunoprecipitates (data not shown).
Experiments with Membrane-Reconstituted SNARE Complexes
SNARE complexes were assembled from purified full-length SNAP-25
and fragments from syntaxin 1A (residues 183–288) and synaptobrevin
2 (residues 1–96) in 1% b-octylglucoside and were reconstituted at
a 1:1000 protein:lipid ratio into liposomes with a synaptic lipid compo-
sition (41% POPC, 32% DPPE, 12% DOPS, 5% PI, and 10% choles-
terol [w/w]; Chen et al., 2006). Microfluidic channels (0.2 mm width,
0.2 mm height, 25 mm length) were formed using standard soft lithog-
raphy techniques (Xia and Whitesides, 1998). Lanes of supported bila-
yers within microfluidic channels were formed with the vesicle fusion
method (Brian and McConnell, 1984). A complexin 1 fragment (resi-
dues 26–83) with a V61C substitution was labeled with BODIPY-FL
and imaged on a Leica confocal fluorescence microscope (TCS
SP2). In a typical experiment, 50 nM BODIPY-FL-labeled complexin
was incubated with a deposited supported bilayer for 15min, unbound
complexin was washed out, and unlabeled synaptotagmin 1 fragment
(residues 140–421) was added in the presence of 1 mM EDTA or 1 mM
Ca2+ and incubated with the bilayer for 10min, followed by a wash with
buffer containing either 1 mM EDTA or 1 mM Ca2+, respectively. As
a negative control, fluorescent complexin was added to bilayers lack-
ing reconstituted SNAREs. Competition experiments were performed
analogously (see Figure 3 legend). Data were analyzed with Image J
(NIH) and Origin 6.0 programs and fitted to dose-response models.
Neuronal Cultures and Lentivirus Infection
Primary cortical neurons from E18 or P1 pups of wild-type rats or mice
or from mice lacking synaptotagmin 1 or synaptobrevin 2 (Deak et al.,
2004; Maximov and Su¨dhof, 2005) were infected at 5 days in vitro with
lentiviruses prepared in transfected HEK293T cells and analyzed at
14–16 days in vitro. For all experiments, expression of fusion proteins
was confirmed by immunoblotting and Venus fluorescence. To visual-
ize synaptic boutons, neurons were loaded with FM5-95 (400 mM;
Molecular Probes) by a 90 s incubation in hyperkalemic solution con-1186 Cell 126, 1175–1187, September 22, 2006 ª2006 Elsevier Itaining (in mM) 45 KCl, 95 NaCl, 2 MgCl2, 10 glucose, 10 HEPES, and
2 CaCl2 and washed for 15 min in a normal bath solution containing
(in mM) 140 NaCl, 5 KCl, 2 CaCl2, 0.8 MgCl2, 10 HEPES-NaOH [pH
7.4], and 10 glucose, and images were acquired in an Axiovert 200M
confocal microscope (Carl Zeiss, Inc.).
Electrophysiology
Inhibitory postsynaptic currents (IPSCs) were evoked and analyzed as
described (Maximov and Su¨dhof, 2005). All statistical analyses were
performed with Student’s t test (*p < 0.001).
Supplemental Data
Supplemental Data include Supplemental Results, Supplemental
Experimental Procedures, and five figures and can be found with
this article online at http://www.cell.com/cgi/content/full/126/6/1175/
DC1/.
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